Authors: Fong, L Hou, YF Rivas, A Benike, C Yuen, A Fisher, GA Davis, MM Engleman, EG

Citation: L. Fong et al., Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy, P NAS US, 98(15), 2001, pp. 8809-8814

Authors: Fong, L Brockstedt, D Benike, C Breen, JK Strang, G Ruegg, CL Engleman, EG

Citation: L. Fong et al., Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy, J IMMUNOL, 167(12), 2001, pp. 7150-7156

Authors: Fong, L Brockstedt, D Benike, C Wu, L Engleman, EG

Citation: L. Fong et al., Dendritic cells injected via different routes induce immunity in cancer patients, J IMMUNOL, 166(6), 2001, pp. 4254-4259

Authors: Strober, S Benike, C Krishnaswamy, S Engleman, EG Grumet, FC

Citation: S. Strober et al., Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: Studies of chimerism and anti-donor reactivity, TRANSPLANT, 69(8), 2000, pp. 1549-1554

Authors: Jenkins, DE Yasukawa, LL Bergen, R Benike, C Engleman, EG Arvin, AM

Citation: De. Jenkins et al., Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination, J IMMUNOL, 162(1), 1999, pp. 560-567

Authors: McGrath, MS Benike, C Kuehne, FW Engleman, E

Citation: Ms. Mcgrath et al., Effect of WF10 (TCDO) on antigen presentation, TRANSPLAN P, 30(8), 1998, pp. 4200-4204